相似文献
1
Prostate cancer biology & genomics.前列腺癌生物学与基因组学。
Transl Androl Urol. 2020 Jun;9(3):1481-1491. doi: 10.21037/tau.2019.07.17.
2
Omics in urology: An overview on concepts, current status and future perspectives.泌尿外科学中的组学：概念、现状和未来展望的概述。
Urologia. 2021 Nov;88(4):270-279. doi: 10.1177/03915603211022960. Epub 2021 Jun 25.
3
Androgen Control in Prostate Cancer.前列腺癌中的雄激素控制
J Cell Biochem. 2016 Oct;117(10):2224-34. doi: 10.1002/jcb.25572. Epub 2016 May 11.
4
Current Trends in Personalized Medicine and Companion Diagnostics: A Summary From the DIA Meeting on Personalized Medicine and Companion Diagnostics.个性化医疗与伴随诊断的当前趋势：来自药物信息协会（DIA）个性化医疗与伴随诊断会议的总结
Ther Innov Regul Sci. 2015 Jul;49(4):530-543. doi: 10.1177/2168479015570330.
5
Androgen receptor and miR-206 regulation in prostate cancer.雄激素受体与miR-206在前列腺癌中的调控
Transcription. 2017;8(5):313-327. doi: 10.1080/21541264.2017.1322668. Epub 2017 Jun 9.
6
New approaches to targeting the androgen receptor pathway in prostate cancer.前列腺癌中靶向雄激素受体途径的新方法。
Clin Adv Hematol Oncol. 2021 Apr;19(4):228-240.
7
MicroRNAs as Guardians of the Prostate: Those Who Stand before Cancer. What Do We Really Know about the Role of microRNAs in Prostate Biology?微小 RNA 作为前列腺的守护者：癌症面前的卫士。我们对微小 RNA 在前列腺生物学中的作用究竟了解多少？
Int J Mol Sci. 2020 Jul 7;21(13):4796. doi: 10.3390/ijms21134796.
8
Androgen receptor splice variant-7 expression emerges with castration resistance in prostate cancer.雄激素受体剪接变异体-7 的表达随着前列腺癌的去势抵抗而出现。
J Clin Invest. 2019 Jan 2;129(1):192-208. doi: 10.1172/JCI122819. Epub 2018 Nov 26.
9
Sequencing the transcriptional network of androgen receptor in prostate cancer.前列腺癌中雄激素受体转录网络的测序。
Cancer Lett. 2013 Nov 1;340(2):254-60. doi: 10.1016/j.canlet.2012.11.009. Epub 2012 Nov 27.
10
Mechanisms of prostate cancer cell survival after inhibition of AR expression.雄激素受体（AR）表达被抑制后前列腺癌细胞的存活机制。
J Cell Biochem. 2009 Feb 15;106(3):363-71. doi: 10.1002/jcb.22022.
引用本文的文献
1
A review of tanshinone compounds in prostate cancer treatment.丹参酮化合物在前列腺癌治疗中的综述。
Transl Androl Urol. 2024 Jul 31;13(7):1278-1287. doi: 10.21037/tau-24-49. Epub 2024 Jul 11.
2
Differential Expression of E2F Transcription Factors and Their Functional and Prognostic Roles in Human Prostate Cancer.E2F转录因子在人前列腺癌中的差异表达及其功能和预后作用
Front Cell Dev Biol. 2022 Apr 21;10:831329. doi: 10.3389/fcell.2022.831329. eCollection 2022.
3
A Mini-Review of Flavone Isomers Apigenin and Genistein in Prostate Cancer Treatment.黄酮异构体芹菜素和染料木黄酮在前列腺癌治疗中的综述
Front Pharmacol. 2022 Mar 11;13:851589. doi: 10.3389/fphar.2022.851589. eCollection 2022.
4
Magnetic Fields and Cancer: Epidemiology, Cellular Biology, and Theranostics.磁场与癌症：流行病学、细胞生物学与治疗学。
Int J Mol Sci. 2022 Jan 25;23(3):1339. doi: 10.3390/ijms23031339.
5
Long Non-Coding RNA DARS-AS1 Contributes to Prostate Cancer Progression Through Regulating the MicroRNA-628-5p/MTDH Axis.长链非编码RNA DARS-AS1通过调控MicroRNA-628-5p/MTDH轴促进前列腺癌进展。
Cancer Manag Res. 2020 Sep 10;12:8363-8377. doi: 10.2147/CMAR.S271021. eCollection 2020.
本文引用的文献
1
COSMIC: the Catalogue Of Somatic Mutations In Cancer.COSMIC：癌症体细胞突变目录。
Nucleic Acids Res. 2019 Jan 8;47(D1):D941-D947. doi: 10.1093/nar/gky1015.
2
Prostate cancer screening with prostate-specific antigen (PSA) test: a clinical practice guideline.使用前列腺特异性抗原（PSA）检测进行前列腺癌筛查：临床实践指南。
BMJ. 2018 Sep 5;362:k3581. doi: 10.1136/bmj.k3581.
3
Prostate cancer screening with prostate-specific antigen (PSA) test: a systematic review and meta-analysis.前列腺癌筛查中前列腺特异性抗原（PSA）检测的系统评价和荟萃分析。
BMJ. 2018 Sep 5;362:k3519. doi: 10.1136/bmj.k3519.
4
Multifocal Primary Prostate Cancer Exhibits High Degree of Genomic Heterogeneity.多灶性原发性前列腺癌表现出高度的基因组异质性。
Eur Urol. 2019 Mar;75(3):498-505. doi: 10.1016/j.eururo.2018.08.009. Epub 2018 Sep 1.
5
Sexual Activity and Risk of Prostate Cancer: A Dose-Response Meta-Analysis.性行为与前列腺癌风险：剂量反应荟萃分析。
J Sex Med. 2018 Sep;15(9):1300-1309. doi: 10.1016/j.jsxm.2018.07.004. Epub 2018 Aug 16.
6
Spatial Intratumor Genomic Heterogeneity within Localized Prostate Cancer Revealed by Single-nucleus Sequencing.基于单细胞测序的局限性前列腺癌中肿瘤内空间基因组异质性。
Eur Urol. 2018 Nov;74(5):551-559. doi: 10.1016/j.eururo.2018.06.005. Epub 2018 Jun 23.
7
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.对超过 14 万名男性的关联分析确定了 63 个新的前列腺癌易感性位点。
Nat Genet. 2018 Jul;50(7):928-936. doi: 10.1038/s41588-018-0142-8. Epub 2018 Jun 11.
8
Focal Therapy in Primary Localised Prostate Cancer: The European Association of Urology Position in 2018.原发性局限性前列腺癌的焦点治疗：2018 年欧洲泌尿外科学会立场。
Eur Urol. 2018 Jul;74(1):84-91. doi: 10.1016/j.eururo.2018.01.001. Epub 2018 Jan 17.
9
The Stockholm-3 Model for Prostate Cancer Detection: Algorithm Update, Biomarker Contribution, and Reflex Test Potential.《前列腺癌检测的斯德哥尔摩-3 模型：算法更新、生物标志物贡献和反射测试潜力》
Eur Urol. 2018 Aug;74(2):204-210. doi: 10.1016/j.eururo.2017.12.028. Epub 2018 Jan 10.
10
Zotero 插件